National Foundation for Infectious Diseases Receives Grant from CSL Biotherapies
The grant will be used to convene an October 20, 2007, roundtable of healthcare professionals across industry sectors to share best practice models on vaccinating workers in their respective environments. In addition, NFID also will publish a best practices guide and tool kit that will detail implementation strategies designed to increase healthcare worker immunization rates.
“NFID is pleased to focus its efforts on much-needed improvement in healthcare professionals’ immunization rates,” said Susan J. Rehm, M.D., NFID medical director.
Current research suggests that fewer than 40% of healthcare workers—serving in a variety of settings, including hospitals, nursing homes, assisted living facilities, home healthcare agencies, and doctor’s offices nationwide—receive the annual vaccination, despite adequate supply.
Targeting its supply of vaccines to healthcare worker populations is a central component of CSL Biotherapies' strategy, according to Robert Lefebvre, vice president and general manager of U.S. commercial operations. “We have a situation in the United States where there are enough flu vaccine doses produced each year, but too few people receiving them,” said Lefebvre. “Because of their proximity to at-risk populations, healthcare workers have been identified by the Centers for Disease Control and Prevention as a high-priority audience. Our goal by funding this grant is to help meet this critical public health need, through targeted communications and innovative distribution strategies.”
The NFID grant also will assist in complementary efforts to partner with organizations such as the Service Employees International Union (SEIU) to increase rates of vaccination among unionized healthcare workers.
“More than one million health care workers are united under SEIU Healthcare,” said Dennis Rivera, chairman of SEIU Healthcare. “We know that comprehensive flu education programs that emphasize the importance of healthcare worker immunization to protect them and those they serve from the flu can dramatically increase voluntary vaccination rates. That’s why we are pleased that the NFID is supporting such an important program.”
About NFID
The National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt (501c3) organization founded in 1973 and dedicated to educating the public and health care professionals about the causes, treatment and prevention of infectious diseases. For more information, please visit .
Pluggd Closes $6M Series A Inv
Inotek Pharmaceuticals Secures
Immunicon Corporation Files Un
Buyout Tide Looks to Turn
General DataComm Obtains Finan
American Racing Capital, Inc.
Gov. Perry Announces $1 Millio
Fitch Upgrades Level 3 Ratings
Coffeyville Resources Closes $
General Mills Prices $700 Mill
VF Corp. Secures $400M in Fina
Tech Revival Predicted in IPO
FastSoft Hires Key Sales, Fina
Nanogen Announces $20 Million
Food Quality Sensor Internatio
Aviation Capital Group Announc
Forest Oil Closes Its Previous
WHI Capital Partners Invests i
Solido Receives $6.5M Second R
SynapSense(TM) Closes Series B
Edgeline Holdings Announces Re
Ryland Announces Amendment to
USA Technologies Completes $15
GridPoint Raises $48.5 Million
Meecorp Capital Markets Closes
ID Theft Prevention Provider,
CIT Launches $600 Million Equi
Bausch & Lomb Announces En
Inter-Atlantic Financial, Inc.
Intel Capital Invests $11 Mill
City of Bethlehem to be the Fi
Venture West Funding Arranges
Maveron LLC Invests in Pinkber
Riverside Partners Teams With
Elron Announces $11 Million In
Casero Secures $5.8 Million as
CNET Networks Enters Into New
Inland Western Retail Real Est
